Healthcare -
Medical - Devices - NASDAQ - US
$ 1.1399
-2.91 %
$ 342 M
Market Cap
-0.36
P/E
PACB - COST OF REVENUE
Cost of Revenue PACB - Pacific Biosciences of California, Inc.
117 M
LAST VALUE
21.35%
2 YEAR CAGR
15.69%
5 YEAR CAGR
12.12%
10 YEAR CAGR